7DT2
Strategic design of catalytic lysine-targeting reversible covalent BCR-ABL Inhibitors
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | AUSTRALIAN SYNCHROTRON BEAMLINE MX2 |
| Synchrotron site | Australian Synchrotron |
| Beamline | MX2 |
| Temperature [K] | 100 |
| Detector technology | CCD |
| Collection date | 2020-07-14 |
| Detector | ADSC QUANTUM 315r |
| Wavelength(s) | 0.95372 |
| Spacegroup name | P 21 21 2 |
| Unit cell lengths | 105.692, 132.302, 56.344 |
| Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
| Resolution | 49.076 - 2.300 |
| R-factor | 0.2076 |
| Rwork | 0.206 |
| R-free | 0.23710 |
| Structure solution method | MOLECULAR REPLACEMENT |
| Starting model (for MR) | 2qoh |
| RMSD bond length | 0.003 |
| RMSD bond angle | 0.561 |
| Data reduction software | XDS |
| Data scaling software | Aimless (0.7.4) |
| Phasing software | PHASER |
| Refinement software | PHENIX (1.11.1_2575) |
Data quality characteristics
| Overall | Inner shell | Outer shell | |
| Low resolution limit [Å] | 49.080 | 49.080 | 2.230 |
| High resolution limit [Å] | 2.160 | 8.930 | 2.160 |
| Rmerge | 0.162 | 0.038 | 1.670 |
| Rmeas | 0.175 | 0.042 | 1.817 |
| Rpim | 0.067 | 0.016 | 0.709 |
| Total number of observations | 290468 | 4254 | 22760 |
| Number of reflections | 42873 | 709 | 3569 |
| <I/σ(I)> | 7.2 | 28.6 | 0.9 |
| Completeness [%] | 99.8 | 99 | 97.7 |
| Redundancy | 6.8 | 6 | 6.4 |
| CC(1/2) | 0.997 | 0.999 | 0.460 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION, HANGING DROP | 7 | 277.15 | 1% Tryptone, 0.05M Hepes sodium pH 7, 20% w/v Polyethylene glycol 3350 |






